Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care

NCT05155917 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hyperglycaemic Crisis in Diabetes Mellitus
Diabetic Ketoacidosis
Hyperglycaemic Hyperosmolar Nonketotic Syndrome

Interventions

DRUG: Insulin Glargine 300 UNT/ML [Toujeo]

Sponsor

Changhua Christian Hospital